2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Thyroid Diseases
1
Parathyroid Diseases
1
Neurilemmoma
1
Neoplasms
1
Meningioma
1
Lung Neoplasms
1
Low Grade Glioma of Brain
1
Liver Neoplasms
1
Inflammatory Bowel Diseases
1
Inflammation
1
Glioma
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Interventions
Infliximab
5
Tea
3
Polyethylene Glycols
3
Blood Specimen Collection
3
Standard of Care
2
MEDI2070
2
Lidocaine
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Colonoscopy
2
CT-P13
2
Biopsy
2
Adalimumab
2
sodium phosphate
1
purine
1
prucalopride
1
polyethylene glycol 400
1
picosulfate sodium
1
golimumab
1
fumaric acid
1
cabozantinib
1
Tumor Necrosis Factor Inhibitors
1
Thrombin Time
1
Surveys and Questionnaires
1
Surgical Tape
1
Sulfasalazine
1
Spectrum Analysis, Raman
1
Specimen Handling
1
Single-Balloon Enteroscopy
1
Registries
1
Proctocolectomy, Restorative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammatory Bowel Diseases
×
Hyperspectral Imaging
×
Clear all
NCT04230603
2020-09-16
HSIT
University of Leipzig
Phase NA
Unknown
1,000 enrolled